Home › Compare › TBIO vs DVY

TBIO vs DVY: Dividend Comparison 2026

TBIO yields 3921.57% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBIO wins by $5928317923792.10M in total portfolio value
10 years
TBIO
TBIO
● Live price
3921.57%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5928317923792.13M
Annual income
$5,645,144,171,791,441,000.00
Full TBIO calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — TBIO vs DVY

📍 TBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBIODVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBIO + DVY cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TBIO pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBIO
Annual income on $10K today (after 15% tax)
$333,333.33/yr
After 10yr DRIP, annual income (after tax)
$4,798,372,546,022,725,000.00/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, TBIO beats the other by $4,798,372,546,022,725,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBIO + DVY for your $10,000?

TBIO: 50%DVY: 50%
100% DVY50/50100% TBIO
Portfolio after 10yr
$2964158961896.08M
Annual income
$2,822,572,085,895,720,400.00/yr
Blended yield
95.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TBIO right now

TBIO
Analyst Ratings
8
Buy
6
Hold
Consensus: Buy
Altman Z
-15.6
Piotroski
3/9
DVY
No analyst data
Altman Z
307.5
Piotroski
1/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBIO buys
0
DVY buys
0
No recent congressional trades found for TBIO or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBIODVY
Forward yield3921.57% ✓3.50%
Annual dividend / share$2.00$5.25 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$5928317923792.13M ✓$25.1K
Annual income after 10y$5,645,144,171,791,441,000.00 ✓$437.78
Total dividends collected$5908985646403.93M ✓$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: TBIO vs DVY ($10,000, DRIP)

YearTBIO PortfolioTBIO Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$402,857$392,156.86$11,050$349.62+$391.8K → TBIO
2$15,195,831$14,764,774.15$12,184$361.04+$15.18M → TBIO
3$536,754,727$520,495,188.22$13,409$372.07+$536.74M → TBIO
4$17,756,748,906$17,182,421,348.17$14,730$382.68+$17756.73M → TBIO
5$550,236,533,968$531,236,812,638.47$16,154$392.89+$550236.52M → TBIO
6$15,973,499,921,404$15,384,746,830,057.32$17,688$402.69+$15973499.90M → TBIO
7$434,496,251,181,035$417,404,606,265,133.20$19,338$412.07+$434496251.16M → TBIO
8$11,075,986,607,305,350$10,611,075,618,541,642.00$21,113$421.04+$11075986607.28M → TBIO
9$264,648,366,355,783,070$252,797,060,685,966,340.00$23,020$429.61+$264648366355.76M → TBIO
10$5,928,317,923,792,128,000$5,645,144,171,791,441,000.00$25,070$437.78+$5928317923792.10M → TBIO

TBIO vs DVY: Complete Analysis 2026

TBIO — Stock

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Full TBIO Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this TBIO vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBIO vs SCHDTBIO vs JEPITBIO vs OTBIO vs KOTBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.